Piltch A, Sun L, Fava R A, Hayashi J
W. Alton Jones Cell Science Center, Inc., Lake Placid, NY 12946.
Biochem J. 1989 Jul 15;261(2):395-400. doi: 10.1042/bj2610395.
In the cloned rat thymic endocrine epithelial cell line TEA3A1, treatment with dexamethasone leads to decreased levels of prostaglandin E2, prostaglandin F2 alpha, and thromboxane B2. Dexamethasone treatment also leads to a decrease of both calcium-dependent and calcium-independent phospholipase A2 activity measured in a cell-free assay. Dexamethasone-treated cells also have increased levels of lipocortin-I, a putative modulator of phospholipase A2 activity. The property of calcium-dependent binding of lipocortin to the particulate fraction was used to prepare cytosolic and particulate subcellular fractions which contained phospholiphase A2 activity but no lipocortin-I. Dexamethasone decreased phospholipase A2 activity in both cytosolic and particulate fractions even in the absence of lipocortin, suggesting the presence of a lipocortin-independent mechanism.
在克隆的大鼠胸腺内分泌上皮细胞系TEA3A1中,用地塞米松处理会导致前列腺素E2、前列腺素F2α和血栓素B2水平降低。地塞米松处理还会导致在无细胞试验中测得的钙依赖性和非钙依赖性磷脂酶A2活性均降低。经地塞米松处理的细胞中脂皮质素-I水平也会升高,脂皮质素-I是一种假定的磷脂酶A2活性调节剂。利用脂皮质素与微粒部分的钙依赖性结合特性制备了含有磷脂酶A2活性但不含脂皮质素-I的胞质和微粒亚细胞部分。即使在没有脂皮质素的情况下,地塞米松也会降低胞质和微粒部分中的磷脂酶A2活性,这表明存在一种不依赖脂皮质素的机制。